Back to Search
Start Over
Analgesic α-Conotoxin Binding Site on the Human GABA B Receptor.
- Source :
-
Molecular pharmacology [Mol Pharmacol] 2022 Oct; Vol. 102 (4), pp. 196-208. Date of Electronic Publication: 2022 Aug 09. - Publication Year :
- 2022
-
Abstract
- The analgesic α -conotoxins Vc1.1, RgIA, and PeIA attenuate nociceptive transmission via activation of G protein-coupled GABA <subscript>B</subscript> receptors (GABA <subscript>B</subscript> Rs) to modulate N-type calcium channels in primary afferent neurons and recombinantly coexpressed human GABA <subscript>B</subscript> R and Cav2.2 channels in human embryonic kidney 293T cells. Here, we investigate the effects of analgesic α -conotoxins following the mutation of amino acid residues in the Venus flytrap (VFT) domains of the GABA <subscript>B</subscript> R subunits predicted through computational peptide docking and molecular dynamics simulations. Our docking calculations predicted that all three of the α -conotoxins form close contacts with VFT residues in both B1 and B2 subunits, comprising a novel GABA <subscript>B</subscript> R ligand-binding site. The effects of baclofen and α -conotoxins on the peak Ba <superscript>2+</superscript> current (I <subscript>Ba</subscript> ) amplitude were investigated on wild-type and 15 GABA <subscript>B</subscript> R mutants individually coexpressed with human Cav2.2 channels. Mutations at the interface of the VFT domains of both GABA <subscript>B</subscript> R subunits attenuated baclofen-sensitive I <subscript>Ba</subscript> inhibition by the analgesic α -conotoxins. In contrast, mutations located outside the putative peptide-binding site (D380A and R98A) did not. The key GABA <subscript>B</subscript> R residues involved in interactions with the α -conotoxins are K168 and R207 on the B2 subunit and S130, S153, R162, E200, F227, and E253 on the B1 subunit. The double mutant, S130A + S153A, abolished inhibition by both baclofen and the α -conotoxins. Depolarization-activated I <subscript>Ba</subscript> mediated by both wild-type and all GABA <subscript>B</subscript> R mutants were inhibited by the selective GABA <subscript>B</subscript> R antagonist CGP 55845. This study identifies specific residues of GABA <subscript>B</subscript> R involved in the binding of the analgesic α -conotoxins to the VFT domains of the GABA <subscript>B</subscript> R. SIGNIFICANCE STATEMENT: This study defines the binding site of the analgesic α -conotoxins Vc1.1, RgIA, and PeIA on the human GABA <subscript>B</subscript> receptor to activate Gi/o proteins and inhibit Cav2.2 channels. Computational docking and molecular dynamics simulations of GABA <subscript>B</subscript> R identified amino acids of the Venus flytrap (VFT) domains with which the α -conotoxins interact. GABA <subscript>B</subscript> R alanine mutants attenuated baclofen-sensitive Cav2.2 inhibition by the α -conotoxins. We identify an allosteric binding site at the interface of the VFT domains of the GABA <subscript>B</subscript> R subunits for the analgesic α -conotoxins.<br /> (Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics.)
- Subjects :
- Alanine
Amino Acids
Analgesics chemistry
Analgesics pharmacology
Baclofen pharmacology
Binding Sites
Calcium Channel Blockers pharmacology
Calcium Channels, N-Type genetics
Calcium Channels, N-Type metabolism
GABA Antagonists pharmacology
GTP-Binding Proteins metabolism
Humans
Ligands
Conotoxins chemistry
Conotoxins metabolism
Conotoxins pharmacology
Receptors, GABA-B metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1521-0111
- Volume :
- 102
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Molecular pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 35944919
- Full Text :
- https://doi.org/10.1124/molpharm.122.000543